Nemucore is dedicated to designing, investigating, developing, and commercializing life-saving novel therapeutics for the treatment of ovarian cancer and other unmet medical needs. Ultimately, Nemucore’s products will be part of the personalized medicine revolution occurring in cancer therapies. Our unique focus on reducing the complex nature of manufacturing is expected to enhance the speed by which we translate novel therapeutics to the clinic. As a participant in the National Cancer Institute's Centers for Cancer Nanotechnology Excellence, we are building a state of the art biomanufacturing facility as a national resource for nanomedicine and emerging biopharmaceutical community. Nemucore was founded in 2008 and is based in Worcester, Massachusetts. For more information, please visit http://www.nemucore.com.